Hazlett, Burt & Watson’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Hazlett, Burt & Watson's ABBV Position: Q3 2026 in Review
Hazlett, Burt & Watson held its AbbVie (ABBV) position steady in Q3 2026 at 11,476 shares worth $3M. The position accounts for 0.77% of the portfolio, ranked #25.
Hazlett, Burt & Watson first reported a position in ABBV in Q1 2022 and has held it in 19 quarters since. 2,690 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Hazlett, Burt & Watson held 11,476 shares of AbbVie worth $3M as of Q3 2026.
- Hazlett, Burt & Watson left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.77% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #25 holding.
- Hazlett, Burt & Watson first reported a position in AbbVie in Q1 2022 and has held it in 19 quarters since.
- 2,690 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.